offshore.dev

Binovate Labs

RO Website 11-50 employees

Work at Binovate Labs? Claim this profile — free, takes a minute.

$50 - $99/hr
5.0

3 reviews

External Reviews

Technologies

AWSAWS Marketplace

Services

Incentives ManagementOmnichannel CX PlanningSales Targets SettingSaaS Platform (Fully Managed)On-Premise Cloud Deployment

Notable Clients

AstraZeneca

Binovate Labs builds CEX360, a SaaS platform for pharmaceutical commercial teams managing incentives, sales targets, and customer engagement at scale. The company is based in Romania and built on AWS infrastructure by a team with 15+ years of AWS experience. The platform is live across Europe and the Middle East & North Africa, with on-demand deployment available for the Americas, Asia-Pacific, Oceania, Africa, and mainland China. The founding team includes people who previously ran commercial operations at AstraZeneca, Novartis, Merck, AbbVie, and worked at McKinsey—domain expertise baked into the product from day one.

Services and capabilities

CEX360 addresses three core problems in pharma commercial ops: incentives management, omnichannel customer experience planning, and sales target setting. The platform automates incentive design and administration for sales professionals with full audit trails and compliance controls. It orchestrates customer journeys across touchpoints—HCP engagement, content delivery, channel coordination—with a single source of truth rather than parallel spreadsheets. Target setting moves from static forecasting to deployment-ready plans with visibility at global, regional, and local levels.

The platform integrates into existing infrastructure: CRM systems, content vaults, business intelligence tools, and data warehouses. No parallel system of record. It applies AI to incentive optimization and forecast-driven resource allocation, replacing last-quarter guesswork with evidence-based decisions. Operationally, it eliminates duplicate cycles, misfiled data, and the administrative back-and-forth that slows teams down.

Data sovereignty is central to the design. The platform is GDPR-native and deployed in customer-selected AWS regions. European deployments keep customer data in EU/EEA AWS regions with sub-processors limited to the EU/EEA. MENA deployments apply GDPR controls by default as a baseline, then layer local frameworks (PDPL, NDMO) per market. US deployments are HIPAA-aware. Asia-Pacific and mainland China deployments are PIPL and MLPS-aware. Africa deployments use AWS Cape Town and partner regions. All data stays in the customer's jurisdiction; sub-processor lists, data processing agreements, and architecture summaries are available on request.

Notable work

Viorel Mihailescu, IBEX activities coordinator for Central & Eastern Europe and the Balkans at AstraZeneca, cited the team's industry knowledge and ability to connect client needs with technology innovation. He highlighted their transparent approach to aligning objectives and constraints on both sides. The platform reports measurable outcomes in production: an 83% increase in total touchpoints, 270% increase in ROI, 70% effort and cost savings in incentives administration, and 90% time and effort savings for managers.

How they work

Binovate offers two engagement models: fully managed SaaS delivered via AWS Marketplace, or installation on the customer's own AWS account as an internal cloud deployment. The team handles implementation, data architecture, and ongoing support. AWS regions are customer-selectable at contract time. The platform is available on the AWS Marketplace.

Team and credentials

The founding team validated the product through prior roles running commercial operations at tier-1 pharma companies: AstraZeneca, Novartis, Merck, AbbVie, and McKinsey. The platform has 15+ years of AWS experience embedded in the architecture and is available on the AWS Marketplace. Certifications and compliance controls include GDPR-native design, HIPAA awareness for US deployments, and PIPL/MLPS awareness for mainland China. Privacy controls are applied as the baseline across every deployment worldwide.

Interested in working with Binovate Labs?

Tell them about your project. No commitment, no fees.

Case Studies

Binovate Labs hasn't published any case studies on Offshore.dev yet.

When they do, their project portfolio will appear here.

Client Reviews

Reviews from verified clients

5.0

3 third-party reviews

Binovate Labs hasn't received any verified reviews on Offshore.dev yet.

Client reviews will appear here once they are submitted and verified.

Frequently Asked Questions

What does Binovate Labs specialize in?
Binovate Labs builds CEX360, a SaaS platform for pharmaceutical commercial teams. It handles three core functions: incentives management (automating design and administration for sales teams), omnichannel customer experience planning (orchestrating HCP engagement across touchpoints), and sales target setting (moving from forecasting to deployment-ready plans with full visibility).
Where is Binovate Labs based and deployed?
Binovate Labs is based in Romania. The platform is live today across Europe and the Middle East & North Africa on AWS. It is deployable on demand in the Americas (HIPAA-aware), Asia-Pacific and Oceania, Sub-Saharan Africa, and mainland China (PIPL/MLPS-aware). Data stays in the customer's selected AWS region.
How is CEX360 deployed?
Two options: fully managed SaaS delivered via AWS Marketplace, or installed on your own AWS account as your internal cloud. Either way, Binovate manages implementation, data architecture, and support. You select your AWS region at contract time. Sub-processor lists and data processing agreements are available on request.
What compliance controls does CEX360 have?
The platform is GDPR-native by design. European deployments keep data in EU/EEA AWS regions with EU/EEA-only sub-processors. US deployments are HIPAA-aware. MENA deployments apply GDPR as minimum baseline and layer local frameworks (PDPL, NDMO). Mainland China deployments comply with PIPL and MLPS. All sub-processors and DPAs are available on request.
What outcomes has CEX360 delivered in production?
The platform reports 83% increase in total touchpoints, 270% increase in ROI, 70% effort and cost savings in incentives administration, and 90% time and effort savings for managers across customer deployments in production.
Who is on the founding team?
The team includes people who previously ran commercial operations at AstraZeneca, Novartis, Merck, AbbVie, and worked at McKinsey. The platform is built by a team with 15+ years of AWS experience. Viorel Mihailescu at AstraZeneca cited their industry knowledge and transparent approach to aligning client needs with technology.

Is this your company?

Claim this listing to update your info, respond to reviews, and unlock premium features.

  • ✓ Update your company description and logo
  • ✓ Respond to client reviews
  • ✓ Get a verified badge
  • ✓ Receive buyer inquiries